42nd Annual Meeting of the Society of Toxicology - Events - Theratechnologies, TSX TH, Tesamorelin, Lipohypertrophy, Lipodystrophy treatment

Model and picture are being used for illustrative purposes only.

Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

NEWS AND EVENTS

March 9, 2003

42nd Annual Meeting of the Society of Toxicology, Salt Lake City, United States

TH9507: Embryofetal and Fertility Studies of a Growth Hormone-Releasing Factor (GRF) Analog (PDF : 127.84 K)

TH9507: Safety Studies of a Growth Hormone Releasing Factor (GRF) Analog (PDF : 99.78 K)

Terms of use